Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +387.2% | +128.6% | 2 / 3 | +39.6% | +21.11 pp | +1.14 pp | +5.5% | 0.28 | 12.49 | 131 | +39,6% | 2,1 | +387,2% | 12.49 | 109.51 | −88,6% |
| Pts | 12 | 12 | 8 | 12 | 12 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 7.400 (close price on 2026-10-16)EPS (TTM): 592,6
Financial charts
1.Revenue & growth
VND bn131Q2/26
1.Revenue & growth
VND bn131Q2/26
2.Profit & growth
VND bn1,86Q2/26
3.Profit mix (Penman)
VND bn34,4Q2/26
4.Margins & cost structure
%29.0%Q2/26
5.Returns & cash cycle
% · days4.9%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn783Q2/26
8.Funding & debt health
VND bn · times783Q2/26
9.Revenue backlog
VND bn4,85Q2/26
10.Valuation
times · %12,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %50Q2/26
Adjusted EPS growth, latest quarter
333%
Average adjusted EPS growth, 3 quarters
111%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26